Positives:
-Staff costs down 17% from Q1
-Product manufacturing down 18% from Q1, good work Scott Bliss.
-Nice to see they have finally split "other working capital" into product manufacturing and "admin/corps costs", which slightly dropped by 21k from Q1 to Q2. Even with new head office opening in US.
- CardioCel sales increased by 19% over Q1 (1.6m to 1.9m)
- H2 expected to be stronger than H1, based on history. Will smash $21m forecast.
Negatives:
-Increased lag between sales and cash receipts, expect to see a large receivable balance at 31 Dec due to US financial year end.
Watch out for the tree shake today.
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-27
-
-
- There are more pages in this discussion • 221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.55 |
Change
-0.130(1.11%) |
Mkt cap ! $244.1M |
Open | High | Low | Value | Volume |
$11.71 | $11.89 | $11.41 | $703.3K | 60.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $11.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.83 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 11.550 |
1 | 1341 | 11.500 |
1 | 1000 | 11.400 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
Price($) | Vol. | No. |
---|---|---|
11.830 | 500 | 1 |
11.900 | 1000 | 1 |
12.000 | 5317 | 2 |
12.400 | 198 | 1 |
12.500 | 429 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |